SkinMedica Raises $25.8M

Carlsbad-based SkinMedica has raised $25.8M in venture founding. The Series D funding came from Perseus-Soros BioPharmaceutical Fund, as well as St. Paul Venture Capital. Existing investors Apax Partners and Domain Associates also participated. SkinMedica is commercializing pharmaceuticals for dermatology. Andrew N. Schiff of Perseus-Soros will join the board. More information »